Davidson Investment Advisors Bristol Myers Squibb CO Transaction History

Davidson Investment Advisors

$1.93 Billion
Q1 2024

A detailed history of Davidson Investment Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Davidson Investment Advisors holds 269,911 shares of BMY stock, worth $10.8 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

269,911

Previous 251,510 7.32%

Holding current value

$10.8 Million

Previous $12.9 Million 13.43%

% of portfolio

0.76%

Previous 0.74%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $882,879 - $1 Million	18,401 Added 7.32%	269,911 $14.6 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $311,968 - $372,264	-6,435 Reduced 2.49%	251,510 $12.9 Million
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $345,313 - $386,114	5,965 Added 2.37%	257,945 $15 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $2.63 Million - $2.92 Million	41,270 Added 19.59%	251,980 $16.1 Million
Q1 2023 Aug 22, 2023	SELL	$65.71 - $74.53 $2.71 Million - $3.08 Million	-41,270 Reduced 16.38%	210,710 $14.6 Million

Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $1.35 Million - $1.54 Million	20,614 Added 10.84%	210,710 $14.6 Million
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $252,074 - $298,492	3,681 Added 1.97%	190,096 $13.7 Million
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $983 - $581,525	7,568 Added 4.23%	186,415 $13.3 Million
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $132,967 - $146,443	1,831 Added 1.03%	178,847 $13.8 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $192,125 - $230,375	3,125 Added 1.8%	177,016 $12.9 Million
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $180,733 - $210,692	-3,370 Reduced 1.9%	173,891 $10.8 Million
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $372,711 - $436,583	6,299 Added 3.68%	177,261 $10.5 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $130,072 - $141,649	-2,101 Reduced 1.21%	170,962 $11.4 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $348,681 - $392,164	5,876 Added 3.51%	173,063 $10.9 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $104,220 - $118,101	-1,805 Reduced 1.07%	167,187 $10.4 Million
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $19,928 - $22,083	-347 Reduced 0.2%	168,992 $10.2 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $2.19 Million - $2.56 Million	39,910 Added 30.84%	169,339 $9.96 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $246,291 - $357,918	-5,308 Reduced 3.94%	129,429 $7.21 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $6.63 Million - $8.65 Million	134,737 New	134,737 $8.65 Million
Q3 2017 Nov 09, 2017	SELL	$55.23 - $63.74 $123,715 - $142,777	-2,240 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	2,240	2,240 $124,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85.2B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Investment Advisors with notifications on news.

Account

Davidson Investment Advisors Bristol Myers Squibb CO Transaction History